Brief: EQL Pharma Reports Group's Sales During Q1 Amounted To SEK 37.3 (99.5) Mln
Aug 16 (Reuters) - EQL Pharma AB EQL.TE :
* EARNINGS PER SHARE WERE SEK 0:09 (0:39) FOR QUARTER
* GROUP'S SALES DURING Q1 AMOUNTED TO SEK 37.3 (99.5)
MILLION
* IN JULY, EMANUEL ERIKSSON TOOK OVER AS NEW CFO
* DURING QUARTER, CO DECIDED TO POSTPONE ANNOUNCED LIST
CHANGE
FROM SPOTLIGHT NEXT TO NASDAQ STOCKHOLM'S MAIN MARKET
Further company coverage: EQL.TE
((Reuters.Briefs@thomsonreuters.com;))